AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 36 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,157,000 | -51.7% | 176,683 | -51.1% | 0.02% | -51.1% |
Q2 2021 | $2,397,000 | +22.7% | 360,955 | +5.9% | 0.04% | +9.8% |
Q1 2021 | $1,954,000 | -53.1% | 340,947 | -26.8% | 0.04% | -55.9% |
Q4 2020 | $4,164,000 | -39.8% | 465,795 | -21.6% | 0.09% | -60.4% |
Q3 2020 | $6,913,000 | +30.4% | 593,867 | +79.6% | 0.24% | +22.4% |
Q2 2020 | $5,302,000 | +193.4% | 330,747 | +9.6% | 0.19% | +97.9% |
Q1 2020 | $1,807,000 | -55.1% | 301,725 | -1.1% | 0.10% | -47.6% |
Q4 2019 | $4,028,000 | +6.5% | 305,158 | +0.2% | 0.18% | -11.1% |
Q3 2019 | $3,783,000 | -14.8% | 304,615 | +10.4% | 0.21% | -5.0% |
Q2 2019 | $4,441,000 | +56.7% | 275,821 | +206.3% | 0.22% | +44.1% |
Q1 2019 | $2,834,000 | -10.5% | 90,043 | -6.6% | 0.15% | -32.1% |
Q4 2018 | $3,167,000 | +2.5% | 96,450 | -4.3% | 0.22% | +33.3% |
Q3 2018 | $3,090,000 | +18.4% | 100,762 | +3.4% | 0.17% | +7.0% |
Q2 2018 | $2,610,000 | – | 97,415 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |